GSK and the University of Oxford have launched the GSK-Oxford Cancer Immuno-Prevention Programme, a new research initiative focused on cancer preve ...

Chip giant Nvidia ( NVDA) was more than 11% lower in the first hour of US trading. Industry peer ASML ( ASML) lost 8%, while Arm ( ARM ), Broadcom ( AVGO ), and Micron Technology ( MU) also got ...

The new collaboration between GSK and the Univeristy of Oxford aims to explore cancer prevention through vaccination.

Scientists at a university in the UK are in the midst of creating a breakthrough vaccine that could stop cancer in its tracks ...

Pharmacies play a key role in improving drug development and patient care, offering insights, clinical trial support and ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

Kirkland, Latham, Paul Weiss and others have replaced the likes of Sullivan & Cromwell, Clifford Chance and Slaughter and May ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of market volatility.

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...